[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:generalized-ischemic-myocardial-dysfunction":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":88,"states":89},"Generalized ischemic myocardial dysfunction",13,12,[8,16,22,28,34,40,46,52,57,62,68,74,80],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05511246","Venous Ethanol for Ventricular Tachycardia",[12],"Phase 2","RECRUITING","2026-08-26T02:17:40.683658Z","2026-07-30T01:46:14.457667Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06138873","Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy",[],"2026-08-26T02:17:18.747857Z","2026-05-05T02:43:29.354598Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06703489","Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)",[],"2026-08-26T02:16:44.178623Z","2026-05-05T02:43:28.985700Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07650032","Cryoablation for Monomorphic Ventricular Tachycardia (VTS)",[],"2026-08-26T02:19:00.742020Z","2026-06-17T02:29:30.060243Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT06965621","18F-mFBG Imaging for Myocardial Sympathetic Innervation",[12],"2026-08-26T02:15:00.557154Z","2026-05-05T02:43:28.478570Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT06814587","Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy",[],"2026-08-26T02:19:01.741747Z","2026-05-13T02:55:06.580753Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":50,"content_modified":51},"NCT05965258","Phenotypic Classification of FMR With CMR",[],"2026-08-26T02:19:31.671303Z","2026-05-13T02:55:06.398577Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":44,"content_modified":56},"NCT01076660","Left Ventricular Structural Predictors of Sudden Cardiac Death",[],"2026-05-13T02:55:06.067841Z",{"nct_id":58,"title":59,"phases":60,"status":13,"updated_at":26,"content_modified":61},"NCT01999140","Implantable Cardioverter Defibrillator (ICD Registry)",[],"2026-05-13T02:55:06.081520Z",{"nct_id":63,"title":64,"phases":65,"status":13,"updated_at":66,"content_modified":67},"NCT06610019","Cardiovascular Multimodality Imaging Study",[],"2026-08-26T02:17:05.997056Z","2026-05-13T02:55:06.556690Z",{"nct_id":69,"title":70,"phases":71,"status":13,"updated_at":72,"content_modified":73},"NCT05654272","Development of CIRC Technologies",[],"2026-08-26T02:16:09.452956Z","2026-05-13T02:55:06.368137Z",{"nct_id":75,"title":76,"phases":77,"status":13,"updated_at":78,"content_modified":79},"NCT05478213","Ventricular Tachycardia Mechanisms",[],"2026-08-26T02:15:59.318403Z","2026-05-05T02:43:27.490777Z",{"nct_id":81,"title":82,"phases":83,"status":85,"updated_at":86,"content_modified":87},"NCT06635863","Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat",[84],"Phase 4","ENROLLING_BY_INVITATION","2026-08-26T02:15:56.561131Z","2026-06-16T05:54:07.765872Z",[],[90,94,98,101],{"state":91,"count":92,"slug":93},"Texas",4,"texas",{"state":95,"count":96,"slug":97},"Massachusetts",3,"massachusetts",{"state":99,"count":96,"slug":100},"New York","new-york",{"state":102,"count":96,"slug":103},"Ohio","ohio"]